HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,011,573 | +2.9% | 235,905 | -2.9% | 0.00% | 0.0% |
| Q2 2023 | $8,759,490 | -19.5% | 242,847 | -14.8% | 0.00% | -25.0% |
| Q1 2023 | $10,880,063 | -19.7% | 284,893 | +19.6% | 0.00% | -20.0% |
| Q4 2022 | $13,555,290 | +44.1% | 238,230 | +0.1% | 0.01% | +25.0% |
| Q3 2022 | $9,409,000 | -21.4% | 237,959 | -12.6% | 0.00% | 0.0% |
| Q2 2022 | $11,973,000 | +2.9% | 272,125 | -6.7% | 0.00% | 0.0% |
| Q1 2022 | $11,636,000 | -2.0% | 291,756 | -1.2% | 0.00% | 0.0% |
| Q4 2021 | $11,876,000 | -1.0% | 295,353 | +0.2% | 0.00% | 0.0% |
| Q3 2021 | $11,991,000 | +2.2% | 294,767 | +14.1% | 0.00% | 0.0% |
| Q2 2021 | $11,729,000 | +27.1% | 258,298 | +16.7% | 0.00% | +33.3% |
| Q1 2021 | $9,226,000 | -2.7% | 221,294 | -0.3% | 0.00% | -25.0% |
| Q4 2020 | $9,479,000 | +229.1% | 221,958 | +102.6% | 0.00% | +300.0% |
| Q3 2020 | $2,880,000 | -11.7% | 109,569 | -9.9% | 0.00% | -50.0% |
| Q2 2020 | $3,261,000 | +77.6% | 121,656 | +19.0% | 0.00% | +100.0% |
| Q1 2020 | $1,836,000 | -9.1% | 102,245 | -10.2% | 0.00% | 0.0% |
| Q4 2019 | $2,019,000 | +42.2% | 113,822 | +24.2% | 0.00% | 0.0% |
| Q3 2019 | $1,420,000 | +19.6% | 91,624 | +32.6% | 0.00% | 0.0% |
| Q2 2019 | $1,187,000 | +34.3% | 69,093 | +25.8% | 0.00% | 0.0% |
| Q1 2019 | $884,000 | -12.1% | 54,941 | -20.0% | 0.00% | 0.0% |
| Q4 2018 | $1,006,000 | +0.7% | 68,707 | +25.0% | 0.00% | 0.0% |
| Q3 2018 | $999,000 | +38.0% | 54,981 | +28.1% | 0.00% | 0.0% |
| Q2 2018 | $724,000 | -17.6% | 42,937 | -4.3% | 0.00% | 0.0% |
| Q1 2018 | $879,000 | -27.1% | 44,878 | -24.3% | 0.00% | 0.0% |
| Q4 2017 | $1,205,000 | +15.3% | 59,289 | -1.4% | 0.00% | 0.0% |
| Q3 2017 | $1,045,000 | +84.3% | 60,157 | +36.4% | 0.00% | – |
| Q2 2017 | $567,000 | +13.6% | 44,116 | +14.5% | 0.00% | – |
| Q1 2017 | $499,000 | +29.3% | 38,531 | -1.2% | 0.00% | – |
| Q4 2016 | $386,000 | +21.4% | 39,011 | +46.0% | 0.00% | – |
| Q3 2016 | $318,000 | +37.1% | 26,714 | -2.3% | 0.00% | – |
| Q2 2016 | $232,000 | -11.1% | 27,332 | 0.0% | 0.00% | – |
| Q1 2016 | $261,000 | -31.1% | 27,332 | +24.6% | 0.00% | – |
| Q4 2015 | $379,000 | +37.3% | 21,940 | +6.1% | 0.00% | – |
| Q3 2015 | $276,000 | -39.5% | 20,683 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $456,000 | +55.6% | 20,683 | 0.0% | 0.00% | – |
| Q1 2015 | $293,000 | +91.5% | 20,683 | +30.5% | 0.00% | – |
| Q4 2014 | $153,000 | +4.1% | 15,853 | 0.0% | 0.00% | – |
| Q3 2014 | $147,000 | – | 15,853 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |